BARD1 and breast cancer: Pathogenic/likely pathogenic (P/LP) BARD1 variant carriers have a 17–30% lifetime risk of BC, prompting the National Comprehensive Cancer Network (NCCN) guidelines to recommend annual mammograms starting at age 40, along with annual breast magnetic resonance imaging (MRI)4.